Jason S. Chapman, Ph.D. - Publications

Affiliations: 
2004 University of Wisconsin, Madison, Madison, WI 
Area:
Biochemistry, Oncology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Anding AL, Chapman JS, Barnett DW, Curley RW, Clagett-Dame M. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor. Cancer Research. 67: 6270-7. PMID 17616685 DOI: 10.1158/0008-5472.Can-07-0727  0.574
2007 Mershon SM, Anding AL, Chapman JS, Clagett-Dame M, Stonerock LA, Curley RW. Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs. Bioorganic & Medicinal Chemistry Letters. 17: 836-40. PMID 17112722 DOI: 10.1016/J.Bmcl.2006.10.050  0.572
2003 Chapman JS, Weiss KL, Curley RW, Highland MA, Clagett-Dame M. Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis. Archives of Biochemistry and Biophysics. 419: 234-43. PMID 14592467 DOI: 10.1016/J.Abb.2003.09.001  0.693
2001 Abou-Issa H, Curley RW, Alshafie GA, Weiss KL, Clagett-Dame M, Chapman JS, Mershon SM. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis. Anticancer Research. 21: 3839-44. PMID 11911255  0.6
2001 Weiss KL, Alshafie G, Chapman JS, Mershon SM, Abou-Issa H, Clagett-Dame M, Curley RW. An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies. Bioorganic & Medicinal Chemistry Letters. 11: 1583-6. PMID 11412986 DOI: 10.1016/S0960-894X(01)00230-X  0.604
Show low-probability matches.